The rearrangement and expression of T cell receptor (TCR.) gene segments occurs in a highly ordered fashion during thymic ontogeny of T lymphocytes. To study the regulation of gene rearrangement within the TCR c~/~ locus, we generated transgenic mice that carry a germline human TCR 5 minilocus that includes V~I, V~2, D~3, J~l, J~3, and C~ segments, and either contains or lacks the TCR ~ enhancer. We found that the enhancer-positive construct rearranges stepwise, first V to D, and then V-D to J. Construct V-D rearrangement mimics a unique property of the endogenous TCR 5 locus. V-D-J rearrangement is T cell specific, but is equivalent in c~/3 and 3"/6 T lymphocytes. Thus, either there is no commitment to the c~//~ and 7/~5 T cell lineages before TCR 5 gene rearrangement, or if precommitment occurs, it does not operate directly on TCR ~ gene cis-acting regulatory elements to control TCR 5 gene rearrangement. Enhancer-negative mice display normal V to D rearrangement, but not V-D to J rearrangement. Thus, the V-D to J step is controlled by the enhancer, but the V to D step is controlled by separate elements. The enhancer apparently controls access to J~l but not D~3, suggesting that a boundary between two independently regulated domains of the minilocus lies between these elements. Within the endogenous TCR ot/~5 locus, this boundary may represent the 5' end of a chromatin regulatory domain that is opened by the TCR ~ enhancer during T cell development. The position of this boundary may explain the unique propensity of the TCR di locus to undergo early V to D rearrangement. Our results indicate that the TCR ~ enhancer performs a crucial targeting function to regulate TCR (5 gene rearrangement during T cell development.
Summary
The rearrangement and expression of T cell receptor (TCR.) gene segments occurs in a highly ordered fashion during thymic ontogeny of T lymphocytes. To study the regulation of gene rearrangement within the TCR c~/~ locus, we generated transgenic mice that carry a germline human TCR 5 minilocus that includes V~I, V~2, D~3, J~l, J~3, and C~ segments, and either contains or lacks the TCR ~ enhancer. We found that the enhancer-positive construct rearranges stepwise, first V to D, and then V-D to J. Construct V-D rearrangement mimics a unique property of the endogenous TCR 5 locus. V-D-J rearrangement is T cell specific, but is equivalent in c~/3 and 3"/6 T lymphocytes. Thus, either there is no commitment to the c~//~ and 7/~5 T cell lineages before TCR 5 gene rearrangement, or if precommitment occurs, it does not operate directly on TCR ~ gene cis-acting regulatory elements to control TCR 5 gene rearrangement. Enhancer-negative mice display normal V to D rearrangement, but not V-D to J rearrangement. Thus, the V-D to J step is controlled by the enhancer, but the V to D step is controlled by separate elements. The enhancer apparently controls access to J~l but not D~3, suggesting that a boundary between two independently regulated domains of the minilocus lies between these elements. Within the endogenous TCR ot/~5 locus, this boundary may represent the 5' end of a chromatin regulatory domain that is opened by the TCR ~ enhancer during T cell development. The position of this boundary may explain the unique propensity of the TCR di locus to undergo early V to D rearrangement. Our results indicate that the TCR ~ enhancer performs a crucial targeting function to regulate TCR (5 gene rearrangement during T cell development.
T he ability of the immune system to recognize a diverse universe of antigens results in large part from the process of V-D-J recombination that assembles the genes encoding antigen receptors on T and B lymphocytes (1) (2) (3) . Studies of lymphocyte development reveal that the assembly of antigen receptor genes is under stringent developmental control. The rearrangement of Ig genes occurs in a stepwise fashion during B cell maturation, with initial D to J joining followed by V to D-J joining at the H chain locus, and subsequently, V to J joining at either the g or ~ L chain locus (1) . Similarly, T cell development is characterized by the ordered rearrangement and expression of TCR. genes (4) (5) (6) . The TCR 6 locus is the first to initiate rearrangement, at day 14 of routine fetal thymic development (7, 8) . This is rapidly followed by rearrangement at the TCR 3' and 3 loci, but TCR ot rearrangement does not begin until fetal day 17 (9) (10) (11) (12) (13) . Furthermore, in mice and humans, the rearrangement of distinct Vs and V~ gene segments occurs in a stepwise fashion during fetal and early neonatal life (12, (14) (15) (16) (17) . This is the result of programmed rearrangement rather than cellular selection as a consequence of TCR expression, since TCR gene mutant mice still undergo stepwise TCR 7 and 8 gene rearrangement in the absence of surface TCR 3`/8 expression
(18).
Progress has been made in understanding the mechanism of V-D-J recombination (2, 3) . However, the manner in which complex patterns of gene rearrangement are orchestrated in developing lymphoid cells is only poorly understood. Immature lymphoid ceils display recombinase activity that is dependent upon the expression of the RAG-1 and RAG-2 genes, and that is required for TCR and Ig gene rearrangement (19) (20) (21) (22) . Further, all TCR and Ig gene segments are flanked by conserved heptamer and nonamer recombination signal sequences that are essential substrates recognized by the recombinase machinery (23) . However, recombinase activity and recombination signal sequences by themselves do not appear to provide the specificity implied by the temporal and lineagerestricted rearrangement of specific gene segments. Rather, such targeting appears to occur via modulation of substrate accessibility to the recombinase (1, 3) . How this is accomplished is unclear; transcriptional activity, methylation status, and chromatin structure have all been associated with com-petence for rearrangement (24) (25) (26) (27) (28) (29) (30) . However, Ferrier et al. (31) demonstrated that V-D-J rearrangement of a hybrid TCR /3/Ig H chain locus test substrate integrated into the germline of transgenic mice is absolutely dependent on the presence of the Ig H chain enhancer (Eu) within the construct. This experiment argues that an enhancer can provide a requisite targeting function important for regulating gene rearrangement.
The TCR ot and C3 genes are encoded within a single complex genetic locus, with TCR C3 D, J, and C gene segments located between V~ and J,~ gene segments (7, (32) (33) (34) (35) . This organization dictates the deletion of TCR C3 gene segments in cells with V,~ to J~ rearrangements, y/c3 T cells typically display rearranged % C3, and B genes, but germline TCR ce, whereas ot/~ T cells typically display rearranged or, B, and 3~ genes, with TCR C3 deleted. The decision to rearrange TCR. c~ versus C3 is therefore a critical event in determining the fate of developing T ceils.
A number of studies have addressed the lineage relationship of "y/c3 and ot/~ T cells. Specifically, these studies have asked whether T cell precursors are precommitted to attempt TCR. C3 or ot rearrangement, but not both (36) . Alternatively, T cell precursors might initially attempt TCR C3 rearrangement, and failing the expression of a functional TCR, might then attempt TCR ot rearrangement (11) . Thus, cell lineage could dictate gene rearrangement, or alternatively, gene rearrangement could dictate cell lineage. Because TCR c~//3 lymphocytes typically display TCR o~ rearrangements on both chromosomes and have deleted both copies of the TCR C3 locus, it is not possible to directly deduce the rearrangement potential of the TCR C3 locus in the cells of the c~/~ lineage. Indirect evidence that has accumulated from the analysis of extrachromosomal circular DNA in thymocytes (36) , from transgenic mice that carry rearranged TCR genes (37, 38) , from the identification of a specific TCR C3 deletional rearrangement in thymocytes (39) , and from the identification of lineage-specific silencer elements that regulate TCR ~ expression (40) , all tend to support the notion that T cell precursors may commit to the TCR 3'/C3 or or//3 lineage before gene rearrangement. However, evidence to the contrary also exists, and this tissue has not been resolved conclusively (41, 42) .
To begin to explore the control of TCR gene rearrangement during T cell development, we have generated transgenic mice carrying a germline human TCR C3 minilocus. We find that this construct rearranges in a stepwise fashion that in many ways mimics the endogenous TCR C3 locus. This has allowed us to assess the role of the intronic TCR C3 enhancer in targeting the rearrangement process. Further, since the transgene is not embedded within the TCR c~ locus, we have been able to directly compare the rearrangement of this gene in or//3 and y/c3 T lymphocytes, and thus explore the relationship between lineage determination and gene rearrangement at the TCR or/c3 locus.
Materials and Methods
Constructs. The transgene V~l-V~2-D63-Jrl-J~3-E~-C~ was constructed by stepwise subcloning of previously described germline 44
DNA fragments of the human TCR c5 locus (35) into pBluescript KS + (Stratagene, La Jolla, CA). In the process, all XbaI sites were destroyed except for two that flank Ee.
Step 1: A 3.9-kb XbaI fragment containing D~3 was treated with the Klenow fragment of Escherichia coli DNA polymerase I to generate blunt ends, and was
cloned into similarly blunt-ended and phosphatase-treated XbaIdigested pBluescript.
Step 2: the 10.5-kb BamHI-KpnI fragment containing Je3, E~, and Ce was ligated into BamHI-and KpnIdigested plasmid generated in step 1 to yield D~3-J~3-E~-C~.
Step 3: The 1.8-kb XbaI-XbaI fragment containing J~l was blunt ended as above and cloned into BamHI-digested, blunt-ended, and phosphatase-treated plasmid from step 2 to yield D~3-J~I-J~3-E~-C~.
Step 4: A 3.1-kb XbaI-SalI fragment containing V~2 cloned in pBluescript was linearized within the Va2 coding region by digestion with PvuI, treated with T4 polymerase to generate blunt ends, and religated to generate a 2-bp frame shift.
Step 5: A 3.1-kb EcoRI fragment containing V~I cloned in pBluescript was linearized within the V~I coding region by digestion with BsmI, blunt ended by treatment with T4 polymerase, and phosphatase treated. A single 10-bp ClaI linker was then ligated into this site.
Step 6:
The mutated V~2 fragment generated in step 4 was excised from the plasmid by digestion with XbaI and Sail, blunt ended by Klenow treatment, and cloned into XbaI-digested, blunt-ended, and phosphatase-treated Vrl plasmid from step 5.
Step 7: Insert containing V~I and Ve2 was excised from the step 7 plasmid by digestion with Sail and NotI, and was treated with Klenow to generate blunt ends. This fragment was ligated into Nod-digested, bluntended, and phosphatase-treated plasmid from step 3 to yield Vrl-V~2-J~l-D63-J~3-E~-Cr.
Step 8: The enhancer-negative construct was generated from the step 7 plasmid by digestion with XbaI to liberate a 1.4-kb fragment containing E~, followed by recircularization of the plasmid. Fragment orientations were confirmed at all steps either by digestion with appropriate restriction enzymes, or by nucleotide sequencing using appropriate primers. The V~I and V~2 mutations were confirmed by nucleotide sequence analysis. Nucleotide sequences were obtained after cloning of amplified products into pBluescript KS+ as described previously (16) . Blot Hybridization of Genomic DNA and PCR Products. Genomic DNA was prepared from tissue and cell suspensions by proteinase K digestion according to established procedures (45) . Gel electrophoresis, blotting, hybridization with 32p-labeled probes, and washing were as previously described (46) . The probes used were: 5'J~1, a 0.4-kb XbaI-PstI fragment mapping 5' of J~l that was isolated from the genomic 1.8-kb J61 XbaI fragment; J~l, a 1.4-kb PstIXbaI fragment isolated from the same fragment; and 5' D~3, a 0.5-kb HindlII-PstI fragment isolated from the genomic 3.9-kb XbaI fragment carrying D~3. The C~, V~I, and V~2 probes have been described previously (32, 46) . All probes were radiolabeled by the method of random hexamer priming (47) . Quantitative analysis of blots was accomplished using a betascope (Betagen, Waltham, MA).
Production and Analysis of Transgenic
Antibodies and Flow Cytometry. H57-597 (biotin-conjugated hamster anti-mouse TCK c~/~ IgG), GL3 (K-PE-conjugated hamster anti-mouse TCK 3//6 IgG), 30-H12 (rat anti-mouse Thy-l.2 IgG2b), 53-6.7 (rat anti-mouse CD8 IgG2a), GK1.5 (rat antimouse CD4 IgG), Fc Block (rat anti-mouse FcylI receptor [CD32]), biotin-conjugated hamster IgG isotype control, and streptavidin-PE were obtained from Pharmingen (San Diego, CA). Affinitypurified, K-PE conjugated goat anti-hamster IgG F(ab')2 fragment was purchased from Jackson Immunoresearch Laboratories (West Grove, PA). FITC-labeled goat anti-mouse IgG and FITC-labeled goat anti-rat IgG were purchased from Dako Corp. (Carpinteria, CA).
For flow cytometry, 1-2 x l0 s cells were washed three times in 2% BSA and 0.1% sodium azide in PBS and were incubated in 50 #1 of the same buffer containing 20 #g/ml of appropriate Ab for 30 min at 4~ Cells were washed three times and were then resuspended in 50 #1 of the same buffer containing the appropriate second step reagent for a 30-rain incubation at 4~ in the dark. Cells were again washed three times, resuspended in the same buffer with 1% paraformaldehyde, and were analyzed using a FACScan | (Becton Dickinson & Co., Mountain View, CA).
Cell Isolation. Enriched splenic T cell preparations were generated by passage of spleen cell suspensions over a nylon wool column as described (48) . T cells were further purified by staining with anti-Thy 1.2 and FITC-conjugated goat anti-rat IgG followed by cell sorting using a FACStar | (Becton Dickinson & Co.). Enriched splenic B cells were generated by two rounds of T cell depletion using anti-Thy-l.2 plus rabbit complement (48) . B cells were further purified by staining with FITC-labeled goat anti-mouse F(ab') followed by cell sorting. Thymic el//~ and 3"/6 T cells were purified by two-color staining of thymocytes (107 cells/ml) using biotinconjugated H57-597 and PE-conjugated GL3 (5 #g/ml each), followed by FITC-streptavidin and cell sorting. In some experiments, thymocytes were enriched for CD4-8-cells by two rounds of depletion with 53-6.7 and GK1.5. The purity of sorted populations was assessed by immediate reanalysis of the sorted sample using a FACScan | Human Cell Samples. TCK ~ gene rearrangements in the T cell leukemia Molt-13 (46) , fetal thymocyte clone Solo-15 (16) , and a 12-wk fetal thymocyte T cell culture (16) were previously characterized. A polyclonal V~2 + culture of 3'/~ T cells from a 16-wk fetal liver was kindly provided by Dr. Hergen Spits (DNAX Research Institute, Palo Alto, CA).
Results
Strategy. We constructed a rearrangement substrate from a series of genomic clones carrying germline elements of the human TCR ~ locus ( Fig. 1 ). These included a 3.1-kb fragment carrying V~I, a 3.1-kb fragment carrying V62, a 3.9-kb fragment carrying D~3, a 1.8-kb fragment carrying J61, and a 10.5-kb fragment carrying J#3 and C6 (35, 46) . The latter fragment also contains the previously characterized TCR transcriptional enhancer within the J~3-Cb intron (49). D~3 was included in the construct because it is the one human D~ segment that is almost universally used in rearranged TCR ~ genes (16, 17, 34) . The V~I and V~2 gene segments were both included within the construct because they appear to be differentially activated during human fetal thymic development (16, 17) . V~2 rearrangements are abundant in very early fetal thymocytes, whereas V~I rearrangements predominate in late fetal and neonatal thymocytes. Further, V~2 usage is restricted to 3~//~ cells, whereas V~I is used in both 3'/~ and cz/8 cells (50) .
We wanted the construct to serve as an innocuous reporter that would not influence the rearrangement of endogenous TCR genes via the process of allelic exclusion. Therefore, mutations were introduced into both V~I and V~2 to destroy their open reading frames and prevent a rearranged transgene from encoding a functional TCR protein. We also wanted to be able to easily remove the TCR ~ enhancer from the TCR 6 gene rearrangement construct 45 Lauzurica and Krangel final construct, and have the flexibility to clone other regulatory elements in its place. Therefore, all XbaI sites within the construct were destroyed during the process of subcloning (see Materials and Methods), except for two sites that lie between J~3 and C~ and flank the enhancer. Finally, we used oligonucleotide primers specific for V61, V~2, J~l, and J~3 to analyze transgene V-D-J rearrangement by the PCR.
Primers were positioned such that any V-D-J rearrangement would yield a PCIk product of r kb using the appropriate pair of V and J primers. Specific PCR products would not be generated from unrearranged templates because of the much larger distances between primers.
V-D and V-D-J Rearrangement of an Enhancer-positive TCR 8 Minilocus.
The linearized 22.4-kb enhancer-positive construct was microinjected into fertilized C57BL/6 x SJL F2 eggs. Southern blot analysis identified three founders that carried a single copy of the minilocus (data not shown). One of these, founder F62, carried an intact minilocus as judged by EcoRI digestion and analysis with V~I, V~2, and C~ probes. Another, founder F57, carried a minilocus that was disrupted at the 3' end. Of two EcoRI fragments detected by a C~ probe, the 5' fragment appeared normal, but the 3' fragment was altered. Since the results obtained with mice derived from these founders were qualitatively similar (see below), the structural alteration in the 3' portion of C~ does not significantly influence construct rearrangement. A third founder, F63, carried a minilocus with a 5' truncation that deleted the V~I gene segment, but retained the V~2 gene segment. Founders were mated with C57BL/6 x SJL F1 mice to establish three transgenic lines (line A, derived from F57; line B, derived from F62; and line C, derived from F63). We noted that the transgene was inherited by all males in line B, suggesting that the transgene had integrated into the Y chromosome. Lines A and B were used for most of the experiments reported in this study.
To assess transgene rearrangement, genomic DNA was prepared from various tissues of two mice in each of transgenic lines A and B. PCR was performed for 25 cycles using appropriate pairs of V and J primers. The products were electrophoresed through agarose gels, transferred to nylon membranes, and hybridized with radiolabeled cDNA probes specific for the human Vel and V62 gene segments for detection. Parallel samples were analyzed by PCR with a pair of C~ primers, and were detected with a radiolabeled C~ probe. These primers amplify a 0.3-kb fragment that is independent of construct rearrangement and therefore serves as a control for the efficiency of PCR in different DNA samples. The combinations of PCR primers and radiolabeled probes used detect rearrangements of the human TCR 8 transgene, but do not detect rearrangements of the endogenous murine TCR, gene (data not shown).
As can be seen in Fig. 2 , each pair of V and J primers amplified products that were enriched in the thymus of neonatal mice (A-26 and B-29) and in the thymus and spleen of older mice (A-48 and B-31). High levels of PCR products in neonatal thymus and low levels in neonatal spleen could be consistent with T cell-specific rearrangement, since there are only small numbers of T lymphocytes in the spleen at this age (data not shown). The low level of PCR products detected in other tissues is most likely attributable to blood contamination. PCR using C~ primers did not reveal significant differences in PCR efficiency from the various DNA sources within each panel.
The most abundant PCR product detected in thymus DNA with each primer pair was approximately 0.3 kb, consistent with the expected size of a V-D-J rearrangement. However, using the primer combinations V~2-J~l and V~l-J~l, we also detected a product of 1.2 kb (Figs. 2 and 3 A) . A product of this size is predicted to result from a partial rearrangement of V~l or V~2 to D~3. Because D83 and J~l are separated by only 0.9 kb in the germline configuration, the combination of a V~I or V~2 primer with a J~l primer could amplify a V-D rearranged fragment of 1.2 kb that contains the 0.9-kb genomic segment between D~3 and J~l (Fig. 3 B) . This rearrangement would not be detected with a J~3 primer, since the distance between D~3 and J~3 is much greater. To prove that the 1.2-kb fragment indeed represented a V-D rearrangement, Southern blots carrying this fragment were probed with a radiolabeled fragment (5' J~l) derived from the region between D~3 and J~l. Whereas the V~I probe hybridized with both the 1.2-and 0.3-kb fragments, the 5' J~l probe selectively hybridized with the 1.2-kb fragment, thereby identifying it as a V~I-D~3 rearrangement (Fig. 3 A) . The partial V61-D~3 and V~2-D~3 rearrangements are likely to be intermediates in the process of transgene V-D-J rearrangement.
Transgene V-D-J and V-D rearrangement was a consistent property of the minilocus in independent lines of transgenic mice. Using V~2 and J~l primers, we detected V~2-D~3-J61 and V~2-D~3 rearrangements not only in line A and line B thymus samples, but in line C thymus samples as well (Fig. 3 C) . Furthermore, the same primer pair was used to identify abundant V62-D~3-J~l and V~2-Dn3 rearrangements in T cell samples derived from human fetal liver and human fetal thymus (Fig. 3 C) . Thus, as revealed by this PCR analysis, transgene rearrangement parallels the rearrangement of the endogenous human TCR 6 locus.
A second potential intermediate in transgene rearrangement is D-J. We could not detect a 0.3-kb fragment representing D~3-J~I rearrangement by PCR using 5' D~3 and J~l primers, even though these primers did amplify a 1.2-kb fragment originating from unrearranged chromosomes (data not shown). Furthermore, we did not detect the predicted D~3-J61 fragment using a J~l probe to analyze Southern blots (see below). We therefore conclude that the transgene rearranges stepwise, and that the predominant pathway involves early rearrangement of V to D, and subsequent rearrangement of V-D to J. The identification of abundant transgene V-D rearrangement intermediates is quite striking, because rearrangements at the Ig H chain locus and at the TCR B locus are well documented to proceed exclusively via D-J intermediates (1) . However, studies of murine fetal thymocyte hybridomas (8) and human leukemias (51, 52) have shown that early V-D rearrangement is a unique property of the endogenous TCR ~ locus (Fig. 3 C) , and this property is clearly mimicked by the transgene. The rearrangement of the transgene differs slightly from the rearrangement of the en-
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Enhancer Control of TCR ~5 Gene Rearrangement Log dilution Figure 4 . Quantification of TCR ~ minilocus V-D-J rearrangement. Serially diluted samples of A-48 thymus DNA, human "//6 T cell Molt-13 DNA, and human 3'/6 T cell Solo 15 DNA were subjected to PCR using the indicated primer pairs and analyzed on Southern blots using Vel and V~2 probes. Amplified 0.3-kb products were quantified using a betascope.
displayed Ve2-D~3-Je3 rearrangements. This difference is not reflected in Fig. 2 because autoradiographic exposures of panels developed with the V~2 probe were adjusted to those developed with the V~I probe, so that rearrangement specificity in lymphoid and nonlymphoid tissues could be compared within each panel. A more accurate reflection of the relative abundance of different rearrangements in line A thymus DNA is presented in Fig. 9 in which the specific activities of the probes and the autoradiographic exposure times were matched. We could not reliably quantify transgene V-D rearrangements by PCR because we did not have single-copy V~I-D~3 and V~2-D~3 rearrangement controls for comparison. Therefore, we attempted to quantify the rearrangements by analyzing Southern blots of PstI-plus EcoRI-digested A-26 thymus DNA using V~I and J,1 probes (Fig. 5) . We detected an abundant rearranged fragment of 1.7 kb with both the Vbl and J~l probes and an equally abundant fragment of 3.2 kb with the V~I probe, as predicted for V~I-D~3-J~I and V~I-D~3-J~3 rearrangements, respectively. Further, we identified another rearranged fragment of 0.9 kb with the V~I probe, as predicted for V~I-D~3. By comparing the intensities of 
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Enhancer Control of TCR 6 Gene Rearrangement (Left) Numbers indicate V~ segment used. Palindromic "P" nucleotides and template independent "N" nucleotides are identified.
the signals for the rearranged fragments detected with the V~I probe, we estimate that "15% of the V~I rearrangements in A-26 thymus are partial V+I-D~3 rearrangements. Consistent with the PCR data, partial D~3-J+I rearrangements of 4.1 kb were not detected.
Fine Structure Analysis of V-D-J Junctions.
The recombination signal sequences 3' of V~ and D~ gene segments display 23-bp spacers, whereas those 5' of D~ and J~ gene segments display 12-bp spacers (33) (34) (35) . Thus, both V-D-J and direct V-J rearrangement would be allowed according to the 12/23 rule. Because of the small size of the D element, PCR products derived from these two classes of rearrangements would be indistinguishable by agarose gel electrophoresis. To determine whether the 0.3-kb fragments indeed represented V-D-J rearrangements typical of rearranged endogenous TCR genes, the PCR. fragments were cloned and then subjected to nucleotide sequence analysis. The V-D-J junction sequences of eight clones derived from fetal thymus and nine clones derived from neonatal thymus were determined (Fig. 6) . All of the junctions show evidence of D segment usage. Further, the junctions display all the hallmarks of typical TCR ~ V-D-J rearrangements, including the evidence of P nucleotides, exonucleolytic digestion of coding ends, and incorporation of template independent N nucleotides (14, 16, 34, 54) . As is the case for endogenous TCR/~ V-D-J junctions, and in accord with the known pattern of terminal transferase expression (55, 56) , N nucleotides were absent from fetal thymocytejunctions (14, 16, 17, 54) . Rather, all nucleotides in these junctions could be assigned as encoded by germline elements or as palindromic P nucleotides that are thought to result from the resolution of hairpin structures at the coding ends (54, 57) . In contrast, N nucleotide incorporation was extensive in the junctions of neonatal thymocytes.
Lineage Specificity of TCR 8 Minilocus Rearrangement.
Since transgene rearrangement is detected at high levels only in thymus and spleen (Fig. 2) , it must, at a minimum, be lymphoid specific. To establish whether rearrangement occurs selectively in T lymphocytes, T and B cell populations were purified from line A and B spleens by a combination of cytotoxic elimination and cell sorting. PCK analysis using V~I and J~l primers revealed transgene V-D-J rearrangement to be abundant in splenic T cells, but undetectable in splenic B cells (Fig. 7 A) . Transgene V-D rearrangement was highly enriched in splenic T cells, but could nevertheless be detected at low levels in splenic B cells. This was true both in the B cell preparation from mouse A-45, where the 1.2-kb V-D product was readily detected, and in the B cell preparation from mouse B-129, where this fragment was detected on longer exposures of the autoradiogram. This is clearly not due to residual T cell contamination, because the specificity of V-D-J rearrangement appeared absolute. Similar analysis of V~1-J63, V~2-J~l, and V~2-J~3 rearrangements indicated that transgene V-D-J rearrangement was T cell specific in all instances (Fig. 7 B) .
We next sought to determine whether transgene rearrangement occurred equivalently in ot/~/and 3'/~ T cells, or occurred preferentially in one of these cell populations. A combination of cytotoxic elimination and cell sorting was used 49 Lauzurica and Krangel to isolate purified populations of oe/B and 3r T cells from neonatal thymus. PCR analysis using V~I and J~l primers revealed essentially equivalent levels of V-D and V-D-J rearrangements in ~/8 and ol/B T lymphocytes (Fig. 8) . This experiment was repeated with additional analysis of V~l-J~3, V~2-J~l, and V~2-J~3 rearrangements, without any evidence for an enrichment of transgene rearrangement in the 3"/8 T cell population (data not shown). Cross-contamination of cell populations was <1% when sorted populations were reanalyzed by flow cytometry. Minilocus rearrangement in oe//3 cells is consistent with our observation that a large fraction of neonatal thymocytes rearrange the transgene (Fig. 4) 
Rearrangement of an Enhancer-negative TCR 8 Minilocus.
To determine whether the TCR 8 enhancer plays an important role in regulating the rearrangement process, plasmid containing the enhancer-positive minilocus construct was modified by XbaI digestion followed by recircularization to delete the 1.4-kb fragment that includes the enhancer. The linearized 21-kb enhancer-negative minilocus construct was then used to generate transgenic mice as above. Four independent founders were identified that carried intact versions of the enhancer-negative minilocus. Three of these, F18, F19, and F22, carried single-copy integrations, whereas one, F25, carried multiple copies of the minilocus. Progeny derived from F25 segregated two different integration sites, one with a single copy, and one with two to three copies of the minilocus. As a result, a total of five different enhancer-negative transgenic lines were derived from the four founders. These were designated lines E (from F22), F (from F18), G (from F19), H (from F25 multicopy integration), and I (from F25 singlecopy integration). The analysis of minilocus rearrangement in thymus DNA from neonatal mice in each of these transgenic lines is presented in Fig. 9 . Thymus DNA from enhancer-positive line A served as a control. In this experiment, V~I and V~2 probes were matched for specific activity, and autoradiographic exposure times were identical, allowing for a meaningful comparison of the relative frequencies of the different rearrangements. Three different rearrangement phenotypes were discerned among the enhancer-negative mice. The most common pheno- Thymus DNA from enhancer-positive (E+) mouse A-26 and enhancernegative (E-) mice E-15 (2.5-wk-old), F-35 (1.5-wk-old), G55 (2.5-wkold), H-46 (2.5-wk-old), and 1-44 (2.5-wk-old) were amplified by PCR using the indicated primers, and Southern blots were developed using appropriately radiolabeled probes. Probe-specific activities and autoradiographic exposures were similar. type was shared by lines E, F, and H. In these mice, minilocus V-D rearrangement appeared to occur normally. Strikingly, however, V-D-J rearrangement was not detected, indicating that the V-D to J step was selectively impaired. This PCR data was confirmed by an analysis of PstI plus EcoRI digests of line H DNA on Southern blots using a V~I probe (Fig.  5) . A V~I-D~3 rearranged fragment of 0.9 kb was readily detected, but V~I-D~3-J~I and V~I-D~3-J~3 rearranged fragments of 1.7 and 3.2 kb, respectively, were not detected, even on longer exposures of the autoradiograph. Confirmatory Southern blot data were also obtained for transgenic line F (data not shown).
Although the level of total V rearrangement (i.e., V-D + V-D-J) varied among these lines of mice, the observed inhibition of the V-D to J step is independent of this variation. We estimate from the Southern blot in Distinct phenotypes were displayed by lines G and I. In line G, no rearrangement was detected. However, in line I, 50 Enhancer Control of TCR ~ Gene Rearrangement significant levels of V-D-J rearrangement were detected, albeit at frequencies that were reduced compared with those in the enhancer-positive line A. Because V-D and V-D-J rearrangement still occurred in the enhancerless construct in line I, we analyzed T and B lymphocyte populations purified from line I splenocytes to ask whether the T cell specificity of rearrangement was retained or lost. We found that V-D-J rearrangement in line I was still T cell specific, and that V-D rearrangement was still highly enriched in T cells (data not shown). The simplest interpretation of this observation is that there are regulatory dements within the construct other than the TCR 5 enhancer that can function to restrict rearrangement to T cells. The analysis of additional animals in each of enhancernegative lines E-I indicated that the qualitative phenotypic differences between the mice analyzed in the above experiment are reproducible properties of the respective lineages. We conclude from these experiments that transgene V to D rearrangement is essentially normal in the absence of the TCR enhancer, whereas V-D to J rearrangement is severely impaired. We think that the quantitative differences in the level of transgene rearrangement in the enhancer-positive andnegative lines, as well as the phenotypic variability among the enhancer-negative lines, most likely results from the dominant effects of the different transgene integration sites. Such position effects on transgene expression are common unless locus control regions are included within transgene constructs (58) (59) (60) (61) . We suspect that the integration site in line G is particularly inert and functions to repress transgene rearrangement, whereas the integration site in line I is particularly active and partially reverses the enhancer-negative phenotype. Nevertheless, three of three enhancer-positive lines undergo V-D-J rearrangement, whereas three of five enhancer-negative lines undergo V-D rearrangement but do not proceed to V-D-J rearrangement. These results argue persuasively that the TCR enhancer performs a crucial targeting function that regulates a specific step in TCR 6 gene rearrangement during T cell development.
Discussion
To begin to dissect the regulation of TCR gene rearrangement during T cell development, we generated transgenic mice with integrated copies of a human TCR ~5 minilocus. The minilocus contained selected segments of the endogenous TCR ~ locus, including the V~I, V~2, D63, J~l, J~3, and C~ gene segments. Transgene V-D-J rearrangement was found to occur exclusively in T lymphocytes. In this and other respects, transgene rearrangement conserved significant features of the rearrangement of the endogenous TCR 5 locus. Thus, although large portions of the endogenous locus are excluded from the minilocus construct, important c/s-acting elements that control the rearrangement process are apparently conserved.
Because we detected high levels of transgene V-D and V-D-J rearrangements, but could not readily identify transgene D-J rearrangements, our data indicate that the minilocus rearranges in stepwise fashion, first V to D, and then V-D to 51 Lauzurica and Krangel (8) and in human fetal liver and fetal thymus T cell samples (Fig. 3 C) . Finally, we have commonly detected D~2-D#3-J~I rearrangements as a 2.8-kb XbaI fragment in DNA from human 3'/6 T cell clones and polyclonal postnatal thymocytes using a J~l probe, but have not observed a 4. We found no evidence for direct joining of V to J, despite the fact that V to J joining should be allowed according to the 12/23 rule. On the contrary, all sequenced junctions showed evidence of D~3 usage. This result is not due to selection for a functional TCR protein, because mutations were introduced into the V regions to destroy their open reading frames. Thus, D~3 usage must be dictated by the rearrangement mechanism itself. Early activation of V and D segment accessibility coupled with efficient V-D joining would insure the incorporation of D~3 in rearranged transgenes.
D63 is almost universally found in rearranged human TCR ~ genes, as is the homologous D~2 in rearranged murine TCR ~ genes (14, 16, 17, 34, 54) . This is also likely to result from ordered rearrangement rather than from selection for a functional TCR, because this is a property of both in-frame and out-of-frame rearranged human and murine TCR genes and a property of rearranged TCR ~ genes in mutant mice that do not express a TCR 3'/5 (18) . By contrast, the usage of murine D~I and human D~I and D62 is not universal, and appears to be developmentally regulated (14, 16, 17, 54) . Together, these data suggest that human D~3 and murine D62 may be the earliest gene segments to be activated within the endogenous TCR 5 loci.
The lineage relationship between or//3 and 3'/6 T cells has been the subject of much discussion. It was initially proposed that thymocytes might first activate TCR 6 and then TCR ot rearrangement in an attempt to generate a functional TCR, with the outcome of the rearrangement process dictating cell lineage (11) . Subsequently, Winoto and Baltimore (36) analyzed extrachromosomal circles that are the products of V~ to J,~ rearrangement, and found TCR 6 to be in the germline configuration in such products. This result would be consistent with a lineage decision before gene rearrangement that dictates TCR ~ or ot rearrangement. In support of this interpretation, other investigators have shown that c~/~ T lymphocyte development can occur in transgenic mice carrying functionally rearranged TCR 3' and c5 genes (37, 38) . However, the analysis of gene rearrangements in routine fetal and neonatal thymocyte hybridomas has clearly shown that TCR and o~ rearrangements can coexist in individual T cell clones (42) , and in one study, rearranged TCR ~ genes were detected in extrachromosomal circular DNA (41) .
We found minilocus V-DoJ rearrangement to be essentially equivalent in or//3 and 3//6 T cells. This clearly implies that the cis-acting elements within the minilocus construct that control rearrangement do not respond to signals that direct lineage commitment. This result would be consistent with the view that there is no lineage commitment before gene rearrangement. However, it is also possible that a lineage commitment step could precede and therefore influence rearrangement, but that our minilocus construct does not include the cis-acting regulatory elements that are responsive to the commitment signal. Plausible candidates for these elements might be 6 Rec and pseudo-J,~ (33, 39, 62) . These elements were shown to rearrange in the thymus and mediate deletion of the TCR 6 gene, and the activation of this rearrangement was postulated to be a mechanism whereby thymoc-ytes would commit to the TCR or//3 lineage. However, evidence to indicate that this represents the major pathway to TCR ot gene rearrangement in vivo has been lacking. Our results indicate that without intervention by 6 1Kec (or perhaps, TC1K ot rearrangement), the TCIK 6 gene could rearrange in virtually all developing thymocytes. Thus, a temporal competition between 6 1Kec (or TCR or) and TCR ~ rearrangement within T cells precommitted to the or//3 lineage might determine the frequency with which TC1K 6 rearrangements occur in the or//3 lineage. Our results are clearly consistent with the detection of TCR 6 and ot rearrangements on homologous chromosomes of some T cell clones (42) .
The analysis of TCR 6 gene rearrangement in an enhancernegative minilocus argues that the two steps in the rearrangement pathway, V to D and V-D to J, are controlled by separate regulatory elements. Only V-D to J rearrangement is severely impaired in the absence of the enhancer. It is generally accepted that gene segments are activated to rearrange by modulating their accessibility to components of the recombinase machinery (1, 3) . Further, enhancer elements can function to modify regional chromatin accessibility (63, 64) . Because V to D rearrangement still occurs in the enhancernegative minilocus, we infer that the TCR 3 enhancer influences the accessibility of the J,1 and J63 segments within the construct, but does not significantly influence the accessibility of D~3 (see Fig. 10 ). This result is quite striking, because J61 and D~3 are separated by only 0.9 kb, both in the minilocus and in the endogenous TCR 3 locus.
Our results argue that there are probably distinct cis-acting elements within the construct that control access to Da3 (and to V~ gene segments). Further, our results imply the presence of a domain boundary between Da3 and Jal that limits the TCR ~5 enhancer to influence J segment but not D segment accessibility and reciprocally, limits more 5' regulatory elements to influence D segment but not J segment accessibility.
Boundary elements that define independent domains of gene activity that are insulated from adjacent regulatory influences play an important role in gene expression (for a review see references 65, 66) . Transgenes flanked by these boundary elements can be insulated from position effects (58) (59) (60) (61) 67) , promoters flanked by these elements can be insulated from a nearby enhancer (67) (68) (69) , and mutational loss of boundary elements has been implicated in misregulated gene expression (70) . Our data suggest that an insulator that is perhaps analogous to the chicken lysozyme A element, the Drosophila 87A7 scs element, or the chicken fl-globin 5'HS4, may reside between Da3 and J~l, and may play an important role in regulating stepwise rearrangement of the TCR ~ gene.
Within the endogenous TCP,. or~6 locus, this insulator may demarcate the 5' boundary of a regulatory domain in chromatin that is opened by the TCR 6 enhancer during T cell development. We predict the 3' boundary to lie between Ca and J~ gene segments.
It is of interest to contrast our results with those of Ferrier et al. (31) , who studied the role of the lymphoid specific Ig H chain enhancer (E~) in the rearrangement of a hybrid TCR./Ig Va-Dt3-J~-E~-C~ test construct. In the presence of E~, construct D-J rearrangement was detected in B and T cells, construct V-D-J rearrangement was detected in T cells, and construct V-D rearrangement was essentially undetectable. In the absence of E~, all construct rearrangement was ablated. These data were interpreted to indicate that D to J rearrangement is controlled by E~, whereas V to D-J rearrangement requires, in addition to E~, tissue-specific regulatory elements associated with V~. Because no rearrangement occurred without Eu, the enhancer must in this case con- 
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Enhancer Control of TCR 6 Gene Rearrangement trol access to both D andJ segments. In the TCR 6 minilocus, V to D joining is independent of the nearby TCR 6 enhancer, arguing that the enhancer controls access toJ segments only. The difference may be that the boundary element that we propose to exist between De and Je segments may not be present in the analogous position in the TCR fl and IgH loci. In the TCR 3 and IgH loci, which are characterized by early D-J rearrangement, early activation of E0 or E, presumably initiates D-J rearrangement before V segments are available. In the TCR 6 locus, which is characterized by early V-D rearrangement, activation of V and D segments presumably occurs before enhancer-dependent activation of J segments. The observation that human lymphoid precursor ALL samples display TCR 6 V-D and D-D rearrangements (but not D-J and V-Dq), whereas T-lineage ALL samples display V-D-J rearrangements (51, 52) , could indicate that the TCR enhancer is activated in the latter, but not the former cell population.
Although an important role for the TCK 6 enhancer in targeting rearrangement is clear, the mechanism by which targeting occurs is not. A substantial body of literature has established a tight correlation between the onset of germline transcription and the onset of gene rearrangement, but recent studies argue that transcriptional activity per se may not be causal in driving rearrangement (28, 29, 71) . The enhancer could provide a targeting function that is also important for transcriptional activity, such as a local change in chromatin structure (64) or DNA methylation (27, 29) . Clearly, it will be valuable to assay such parameters across V, D, and J segments within the enhancer-positive and -negative transgenes in future experiments. In addition, c/s elements of the TCR enhancer that are essential for transcriptional activation have been identified (72, 73) and this system offers the opportunity to test the role of such elements in targeting gene rearrangement. Finally, it should be possible to use this system to identify additional regulatory elements that mediate De and V~ gene segment targeting, and that function to define domain boundaries that restrict the influence of regulatory elements to discrete regions of the locus. 
